Four Weibo Influencers Leading the Vaccine Conversation in China
April 28, 2021 | By Xulei Wu, Senior Associate; Marisa Lim, 2021 Spring Intern, Bridge Consulting
Infectious Diseases
How Can International Partners Help China’s Goal to Eliminate Hepatitis C in Nine Years?
March 23, 2021 | By Zixiang (George) Zhou, Associate, Bridge Consulting | Image source: MSF Access Campaign March 18, 2021 marked China’s 21st National Protect Your Liver Day. In 2016, the WHO adopted the Global Health Sector Strategy on Viral Hepatitis, an action plan to end viral hepatitis as a major public health risk by […]
Tracking China’s COVID-19 Vaccine Distribution
Examining China’s Promise to Make Its Vaccines A Global Public Good
Can Logistics Firm Cainiao Help with the Distribution of COVID-19 Vaccines in Africa?
December 24, 2020 | By Zixiang (George) Zhou, Associate, Bridge Consulting African countries are facing serious challenges related to the distribution of COVID-19 vaccines. Cainiao and its parent company Alibaba, which both have growing links to the region and deep logistics expertise, can help deal with some logistics challenges, though it is not without its […]
A Month After China’s Joining of COVAX: Contributions, Progress, and Uncertainties
November 12, 2020 | By Zixiang (George) Zhou, Associate, Bridge Consulting CEPI will fund Clover Biopharmaceuticals’ COVID-19 vaccine through a global Phase 2/3 clinical trial. Other Chinese COVID-19 vaccines continue to make progress, while yet other Chinese companies are developing COVID-19 vaccine global distribution solutions. Nonetheless, controversies over China’s COVID-19 vaccines remain. Although China has […]